Stock listing

E8LA Stock Price, News, Filings & Events — Geovax Labs, Inc.

Selected listing: E8LA · SWB · EUR · DE

This page tracks Geovax Labs, Inc.'s E8LA:SWB listing on SWB in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following E8LA:SWB. E8LA:SWB is the stock-level entry point for investors researching Geovax Labs, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Geovax Labs, Inc. (ticker: GOVX) is a public company based in the United States, focusing on the development of innovative vaccines and immunotherapies. With a market capitalization of approximately $3.81 million, Geovax is engaged in advancing its product pipeline to address various infectious diseases and cancers. The company aims to leverage its proprietary technologies to create effective solutions for global health challenges.

E8LA:SWBEURDEUpdated August 21, 2026
Geovax Labs, Inc. logo
Ticker
E8LA:SWB
Asset type
Stock
Market cap
$4.8M
Sector
Health Technology
Industry
Biotechnology
Exchange
SWB
Currency
EUR

Geovax Labs, Inc. E8LA:SWB stock context

This page tracks Geovax Labs, Inc.'s E8LA:SWB listing on SWB in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following E8LA:SWB. E8LA:SWB is the stock-level entry point for investors researching Geovax Labs, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Geovax Labs, Inc. (ticker: GOVX) is a public company based in the United States, focusing on the development of innovative vaccines and immunotherapies. With a market capitalization of approximately $3.81 million, Geovax is engaged in advancing its product pipeline to address various infectious diseases and cancers. The company aims to leverage its proprietary technologies to create effective solutions for global health challenges.

Latest news from Geovax Labs, Inc.

All Geovax Labs, Inc. news →

Research Geovax Labs, Inc.

Alternate listings